GlaxoSmithKline To Market Merck’s Mevacor OTC In U.S.
An FDA joint advisory committee meets Dec. 13 to evaluate Merck data supporting the Rx-to-OTC switch.
An FDA joint advisory committee meets Dec. 13 to evaluate Merck data supporting the Rx-to-OTC switch.